Telomere-driven diseases and telomere-targeting therapies
Open accessThe DOI matches its Crossref record; 147 of the 148 references it cites were found in a registry or an index.
Abstract
Telomeres, the protective ends of linear chromosomes, shorten throughout an individual’s lifetime. Telomere shortening is proposed to be a primary molecular cause of aging. Short telomeres block the proliferative capacity of stem cells, affecting their potential to regenerate tissues, and trigger the development of age-associated diseases. Mutations in telomere maintenance genes are associated with pathologies referred to as telomere syndromes, including Hoyeraal-Hreidarsson syndrome, dyskeratosis congenita, pulmonary fibrosis, aplastic anemia, and liver fibrosis. Telomere shortening induces chromosomal instability that, in the absence of functional tumor suppressor genes, can contribute to tumorigenesis. In addition, mutations in telomere length maintenance genes and in shelterin components, the protein complex that protects telomeres, have been found to be associated with different types of cancer. These observations have encouraged the development of therapeutic strategies to treat and prevent telomere-associated diseases, namely aging-related diseases, including cancer. Here we review the molecular mechanisms underlying telomere-driven diseases and highlight recent advances in the preclinical development of telomere-targeted therapies using mouse models.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Therapeutic benefits have been observed for AAV-mediated delivery of TERT in animal models of aplastic anaemia, IPF and Alzheimer’s disease164,191.”
From Telomere dysfunction in ageing and age-related diseases (2022) · cites this paper as [191]
Experimental — accuracy not yet measuredIn the citing paper
“Genetic defects in telomere maintenance cause human telomeropathies, including dyskeratosis congenita, aplastic anemia, and pulmonary and liver disease exhibiting multiple progeroid features15.”
From The central role of DNA damage in the ageing process (2021) · cites this paper as [15]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
Li, Y.-J., Jiang, Q., Cao, G.-F., Yao, J., & Yan, B. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373980 · Cited by 16,304
López-Otín, C., Blasco, M. A., Partridge, L., Serrano, M., & Kroemer, G. (2013) · Cell · doi:10.1016/j.cell.2013.05.039 · Cited by 14,982 · cited 3×
“Telomeres shorten progressively throughout an individual’s lifetime (Cawthon et al., 2003; López-Otín et al., 2013; Sanders and Newman, 2013).”
BackgroundSelf-citationSpecific Association of Human Telomerase Activity with Immortal Cells and Cancer
Kim, N. W., Piatyszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L. C., Coviello, G. M., Wright, W. E., Weinrich, S. L., & Shay, J. W. (1994) · Science · doi:10.1126/science.7605428 · Cited by 7,091 · cited 3×
“Indeed, ∼90% of human cancers present telomerase activity (Kim et al., 1994).”
BackgroundAutophagy in the Pathogenesis of Disease
Levine, B., & Kroemer, G. (2008) · Cell · doi:10.1016/j.cell.2007.12.018 · Cited by 7,069 · cited 1×
“MC is driven by a complex and poorly understood signaling cascade that antecedes apoptosis, necrosis, senescence, or autophagy (Levine and Kroemer, 2008; Vitale et al., 2011).”
BackgroundTelomeres shorten during ageing of human fibroblasts
Harley, C. B., Futcher, A. B., & Greider, C. W. (1990) · Nature · doi:10.1038/345458a0 · Cited by 5,750 · cited 2×
“…to counteract telomere attrition associated with cell division throughout life, and therefore telomeres shorten with age in vitro and in vivo (Harley et al., 1990; Hastie et al., 1990; Lindsey et al., 1991; Collado et al., 2007; Liu et al., 2007; Flores et al., 2008; Marion et al., 2009).”
BackgroundAutophagy and Viruses: Adversaries or Allies?
Dong, X., & Levine, B. (2013) · Journal of Innate Immunity · doi:10.1159/000346388 · Cited by 4,430
Identification of a specific telomere terminal transferase activity in tetrahymena extracts
Greider, C. W., & Blackburn, E. H. (1985) · Cell · doi:10.1016/0092-8674(85)90170-9 · Cited by 3,400 · cited 2×
“1 C; Greider and Blackburn, 1985).”
BackgroundShelterin: the protein complex that shapes and safeguards human telomeres
de Lange, T. (2005) · Genes & Development · doi:10.1101/gad.1346005 · Cited by 3,056 · cited 1×
“1 C; de Lange, 2005; Martínez and Blasco, 2010, 2011).”
Mammalian Telomeres End in a Large Duplex Loop
Griffith, J. D., Comeau, L., Rosenfield, S., Stansel, R. M., Bianchi, A., Moss, H., & de Lange, T. (1999) · Cell · doi:10.1016/s0092-8674(00)80760-6 · Cited by 2,447 · cited 2×
“1, A and B; Griffith et al., 1999; Doksani et al., 2013).”
BackgroundTelomere Shortening and Tumor Formation by Mouse Cells Lacking Telomerase RNA
Blasco, M. A., Lee, H.-W., Hande, M. P., Samper, E., Lansdorp, P. M., DePinho, R. A., & Greider, C. W. (1997) · Cell · doi:10.1016/s0092-8674(01)80006-4 · Cited by 2,108 · cited 1×
“…the study of telomerase-deficient mice, which show premature aging phenotypes in both lowproliferating (heart, brain) and high-proliferating compartments (bone marrow [BM], gut, skin, and testis; Blasco et al., 1997; Lee et al., 1998; Herrera et al., 1999; Leri et al., 2003; Ferrón et al., 2004).”
BackgroundSelf-citation
Research works printed but not linked: 1
- Bär, 2016, F1000 Res, 89
Cited by
Items 101–200 of 255
Deb, S., Berei, J., Miliavski, E., Khan, M. J., Broder, T. J., Akurugo, T. A., Lund, C., Fleming, S. E., Hillwig, R., Ross, J., et al. (2024) · Cells · doi:10.3390/cells13110884 · Cited by 17
“Additionally, in the absence of functional tumor suppressor genes, the chromosomal instability caused by telomere shortening can contribute to tumorigenesis [6,7].”
BackgroundTRF1 and TRF2: pioneering targets in telomere-based cancer therapy
Kallingal, A., Krzemieniecki, R., Maciejewska, N., Brankiewicz, W., & Bagiński, M. (2024) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-024-05867-3 · Cited by 17
Ferrara‐Romeo, I., Martínez, P., & Blasco, M. A. (2018) · PLoS ONE · doi:10.1371/journal.pone.0204909 · Cited by 16
Self-citationCalvete, O., García‐Pavía, P., Domínguez, F., Mosteiro, L., Pérez‐Cabornero, L., Cantalapiedra, D., Zorio, E., y Cajal, T. R., Crespo‐Leiro, M. G., Teulé, À., et al. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.119.012875 · Cited by 16
“In normal conditions the shelterin complex protects telomere cap ends in somatic cells by preventing access of the telomerase to chromosome ends.(14) The shelterin complex also masks single-stranded telomeres from the DNA damage response, thereby preventing the activation of ATM (ataxia telangiectasia mutated) and ATR…”
BackgroundDNA End Joining: G0-ing to the Core
Frock, R. L., Sadeghi, C., Meng, J., & Wang, J. (2021) · Biomolecules · doi:10.3390/biom11101487 · Cited by 19
Vascular Senescence: A Potential Bridge Between Physiological Aging and Neurogenic Decline
Rojas-Vázquez, S., Blasco-Chamarro, L., López-Fabuel, I., Martínez-Máñez, R., & Fariñas, I. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.666881 · Cited by 15
“In contrast to other somatic cells, telomerase expression is maintained in tissue-specific SCs after birth, but nonetheless telomeres exhibit attrition in SC populations at advanced ages (Martínez and Blasco, 2017).”
BackgroundTelomere dynamics in human pluripotent stem cells
Ma, B., Martínez, P., Sánchez-Vazquez, R., & Blasco, M. A. (2023) · Cell Cycle · doi:10.1080/15384101.2023.2285551 · Cited by 16
“Indeed, mutations in telomere maintenance related genes have been associated with different human diseases known as telomeropathies that include dyskeratosis congenita, aplastic anemia, and idiopathic pulmonary fibrosis [10–12].”
BackgroundSelf-citationmTert induction in p21-positive cells counteracts capillary rarefaction and pulmonary emphysema
Lipskaia, L., Breau, M., Cayrou, C., Churikov, D., Braud, L., Jacquet, J., Born, E., Fouillade, C., Curras-Alonso, S., Bauwens, S., et al. (2024) · EMBO Reports · doi:10.1038/s44319-023-00041-1 · Cited by 15
“Because TERT may reverse these processes, TERT-based gene therapy (Martínez and Blasco, 2017) may be clinically bene fi cial to treat COPD.”
Dynamics of TRF1 organizing a single human telomere
Li, X., Wang, M., Zheng, W., Huang, W., Wang, Z., Jin, K., Liu, L., & Yu, Z. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa1222 · Cited by 16
Telomere length: biological marker of cellular vitality, aging, and health-disease process
Teixeira, M. Z. (2021) · Revista da Associação Médica Brasileira · doi:10.1590/1806-9282.67.02.20200655 · Cited by 17
Yin, Q., Liu, X., Hu, L., Song, Q., Liu, S., Huang, Q., Geng, Z., Zhu, Y., Li, X., Fu, F., et al. (2021) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114767 · Cited by 18
Effects of age and oligoasthenozoospermia on telomeres of sperm and blood cells
Balmori, C., Córdova-Oriz, I., Alba, G. D., Medrano, M., Jiménez-Tormo, L., Polonio, A. M., Chico-Sordo, L., Pacheco, A., García-Velasco, J. A., & Varela, E. (2021) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2021.10.010 · Cited by 18
Telomere dynamics and oxidative stress in Arabidopsis grown in lunar regolith simulant
Barcenilla, B. B., Kundel, I., Hall, E., Hilty, N., Ulianich, P., Cook, J., Turley, J., Yerram, M., Min, J.-H., Castillo-González, C., et al. (2024) · Frontiers in Plant Science · doi:10.3389/fpls.2024.1351613 · Cited by 14
Castillo, R. D. B., Bleesing, J., McCormick, T., Squires, J. E., Mazariegos, G. V., Squires, J. H., & McKiernan, P. J. (2020) · Pediatric Transplantation · doi:10.1111/petr.13695 · Cited by 14
de Oliveira, B. C. D., Shiburah, M. E., de Paiva, S. C., Vieira, M. R., Morea, E. G. O., da Silva, M. S., Alves, C. D. S., Segatto, M., Gutierrez‐Rodrigues, F., Borges, J. C., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.713415 · Cited by 14
When the Ends Are Really the Beginnings: Targeting Telomerase for Treatment of GBM
Bollam, S., Berens, M. E., & Dhruv, H. (2018) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-018-0825-7 · Cited by 14
Wang, L., Ma, T., Liu, W., Li, H., Luo, Z., & Feng, X. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.859617 · Cited by 14
Genomic Instability Evolutionary Footprints on Human Health: Driving Forces or Side Effects?
Veschetti, L., Treccani, M., Tomi, E. D., & Malerba, G. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411437 · Cited by 17
Telomeres, the loop tying cancer to organismal life‐histories
Újvári, B., Raven, N., Madsen, T. R. L., Klaassen, M., Dujon, A. M., Schultz, A. G., Nunney, L., Lemaître, J., Giraudeau, M., & Frédéric Thomas, A. (2022) · Molecular Ecology · doi:10.1111/mec.16488 · Cited by 17
“…segregation and DNA repair mechanisms resulting in chromosome shattering, mutation accumulation and genome duplications and thus, promote cancer progression via processes such as chromothripsis, kataegis and tetraploidization (Maciejowski & de Lange, 2017; Martínez & Blasco, 2017; Box 1).”
BackgroundKmiołek, T., Filipowicz, G., Bogucka, D., Wajda, A., Ejma-Multański, A., Stypińska, B., Modzelewska, E., Kaliberda, Y., Radkowski, M. J., Targowski, T., et al. (2023) · Immunity & Ageing · doi:10.1186/s12979-023-00384-2 · Cited by 16
“Therefore, they also have the potential to be used as biomarkers for many age-related diseases [12].”
BackgroundShould we consider telomere length and telomerase activity in male factor infertility?
Balmori, C., & Varela, E. (2018) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/gco.0000000000000451 · Cited by 12
Guinobert, I., Blondeau, C., Colicchio, B., Oudrhiri, N., Dieterlen, A., Jeandidier, É., Deschênes, G., Bardot, V., Cotte, C., Ripoche, I., et al. (2020) · Biomedicines · doi:10.3390/biomedicines8020031 · Cited by 12
“Counteracting telomere attrition and its consequences has been a main target for research during the last decade [7,22].”
The Binding Pocket at the Interface of Multimeric Telomere G‐quadruplexes: Myth or Reality?
Manoli, F., Doria, F., Colombo, G., Zambelli, B., Freccero, M., & Manet, I. G. J. (2021) · Chemistry - A European Journal · doi:10.1002/chem.202101486 · Cited by 12
Insights into POT1 structural dynamics revealed by cryo-EM
Smith, E. W., Lattmann, S., Liu, Z. B., Ahsan, B., & Rhodes, D. (2022) · PLoS ONE · doi:10.1371/journal.pone.0264073 · Cited by 14
Öztürk, S. (2024) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2024.111913 · Cited by 13
Telomeres and oocyte maturation rate are not reduced by COVID-19 except in severe cases
Chico-Sordo, L., Polonio, A. M., Córdova-Oriz, I., Medrano, M., Herraiz, S., Bronet, F., García-Velasco, J. A., & Varela, E. (2022) · Reproduction · doi:10.1530/rep-22-0243 · Cited by 11
Pauleck, S., Gigic, B., Cawthon, R., Ose, J., Peoples, A. R., Warby, C. A., Sinnott, J. A., Lin, T., Boehm, J., Schrotz‐King, P., et al. (2022) · Journal of Geriatric Oncology · doi:10.1016/j.jgo.2021.12.008 · Cited by 11
Role of Senescence and Neuroprotective Effects of Telomerase in Neurodegenerative Diseases
Ding, X., Liu, X., Wang, F., Wang, F., & Geng, X. (2019) · Rejuvenation Research · doi:10.1089/rej.2018.2115 · Cited by 12
“19 Telomeres terminate with a single G-strand overhang.”
Balanikas, E., Bányász, Á., Baldacchino, G., & Markovitsi, D. (2020) · Molecules · doi:10.3390/molecules25092094 · Cited by 10
“G-quadruplexes play a key role in important biological functions [1] and constitute therapeutic targets [2,3].”
BackgroundSingaravelu, G., Harley, C. B., Raffaele, J. M., Sudhakaran, P., & Suram, A. (2021) · OBM Geriatrics · doi:10.21926/obm.geriatr.2102168 · Cited by 12
“Attrition of telomere length underpins the aging process itself and the maladies associated with aging [1].”
BackgroundAssociations of Rap1 with Cell Wall Integrity, Biofilm Formation, and Virulence in Candida albicans
Wang, W., Lai, T.-X., Wu, Y., Chen, Z.-T., Tseng, K., & Lan, C. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.03285-22 · Cited by 12
“hRap1 contributes to inflammation related to human diseases (26, 55).”
BackgroundRNA deadenylation complexes in development and diseases
Liu, Y., Ramkumar, N., & Vu, L. (2023) · Biochemistry and Cell Biology · doi:10.1139/bcb-2022-0325 · Cited by 11
Training Performed Above Lactate Threshold Decreases p53 and Shelterin Expression in Mice
Cunha, V. D. C., Rosa, T. D. S., Sales, M. M., Sousa, C. V., Aguiar, S. D. S., Deus, L. A., Simões, H. G., & de Andrade, R. (2018) · International Journal of Sports Medicine · doi:10.1055/a-0631-3441 · Cited by 11
“Mitochondrial oxidative stress (as seen in the sedentary mice muscle) induces nuclear DNA damage [36, 37], and consequent telomere shortening, facilitating p53 translocation from the cytoplasm to the nucleus [27].”
BackgroundErdem, M., Tüfekçi, Ö., Yılmaz, Ş., Alacacıoğlu, İ., & Ören, H. (2018) · Acta Haematologica · doi:10.1159/000494421 · Cited by 10
Rey‐Millet, M., Pousse, M., Soithong, C., Ye, J., Méndez-Bermúdez, A., & Gilson, É. (2023) · Aging Cell · doi:10.1111/acel.13804 · Cited by 11
“Moreover, short telomeres are associated in the general population with a broad spectrum of age- related pathologies, including cardiovascular and neurodegenerative diseases, type II diabetes, pulmonary fibrosis, and arthrosis (Blackburn et al., 2015; Martínez & Blasco, 2017).”
BackgroundMargiana, R., Gupta, R., Al‐Jewari, W. M., Hjazi, A. M., Alsaab, H. O., Mustafa, Y. F., Singh, R., Thaibt, R., Alkhayyat, S., & Ibrahim, A. J. (2024) · Cell Biochemistry and Function · doi:10.1002/cbf.3935 · Cited by 10
Telomerase dynamics in stem cells: Unraveling the molecular nexus of cellular aging and regeneration
Jiang, Y., Zhou, Y., Wang, Y., Li, Z., Ashraf, G. M., & Guo, L. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102853 · Cited by 14
Severe telomere shortening in Fanconi anemia complementation group L
Shah, A., George, M., Dhangar, S., Rajendran, A., Mohan, S., & Vundinti, B. R. (2021) · Molecular Biology Reports · doi:10.1007/s11033-020-06101-2 · Cited by 9
Regulation of telomeric function by DNA methylation differs between humans and mice
Toubiana, S., Larom, G., Smoom, R., Duszynski, R. J., Godley, L. A., Francastel, C., Velasco, G., & Selig, S. (2020) · Human Molecular Genetics · doi:10.1093/hmg/ddaa206 · Cited by 9
TGF-β controls stromal telomere length through epigenetic modifications
Mishra, R., Haldar, S., Biondi, S., Bhari, V. K., Singh, G., & Bhowmick, N. A. (2022) · 3 Biotech · doi:10.1007/s13205-022-03346-5 · Cited by 9
“Telomeres are protective “caps” on eukaryotic chromosomes, composed of long tandem arrays of double stranded TTA GGG repeats bound by specialized array of specialized proteins (Martinez and Blasco 2017; Morin 1989).”
BackgroundKim, C., Bae, H. M., & Baik, I. (2022) · Rejuvenation Research · doi:10.1089/rej.2022.0051 · Cited by 9
“27,28 31 Based on earlier studies, A. membranaceus has been investigated intensively as a potential telomerase activator attenuating telomere length shortening.”
Esc2 promotes telomere stability in response to DNA replication stress
Jørgensen, S. W., Liberti, S. E., Larsen, N. B., Lisby, M., Mankouri, H. W., & Hickson, I. D. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz158 · Cited by 10
“Once telomeres become critically short or dysfunctional, they cause cells to cease dividing and enter a viable, non-dividing cellular state known as senescence (7).”
Akıncılar, S. C., Fidan, K., Kumar, N., Ng, Q. F., Majee, P., Wu, L., Han, D. J., Chan, C. H. T., Chua, J. Y. H., Idzham, K., et al. (2025) · Nature Cell Biology · doi:10.1038/s41556-025-01706-w · Cited by 9
Niazi, S. K. (2025) · Life Sciences · doi:10.1016/j.lfs.2025.123904 · Cited by 8
Chromosome ends and the theory of marginotomy: implications for reproduction
Córdova-Oriz, I., Polonio, A. M., Cuadrado-Torroglosa, I., Chico-Sordo, L., Medrano, M., García-Velasco, J. A., & Varela, E. (2023) · Biogerontology · doi:10.1007/s10522-023-10071-w · Cited by 9
“Moreover, during the reprogramming of somatic cells to induced pluripotent stem cells, telomeres lengthen kilobases in a telomerase-dependent manner (Marion et al. 2009; Martinez and Blasco 2017).”
InfluentialFuturo del tratamiento farmacológico en fibrosis pulmonar idiopática
Molina‐Molina, M. (2019) · Archivos de Bronconeumología · doi:10.1016/j.arbres.2019.05.008 · Cited by 10
“Finalmente, las mutaciones en genes de telomerasa pueden asociar otras enfermedades hematológicas, neoproliferativas, inmunológicas o degenerativas, por lo que este target terapéutico no solo resulta de interés en FPI sino también en otras formas de telomeropatías 42 .”
BackgroundThe future of pharmacological treatment in idiopathic pulmonary fibrosis
Molina‐Molina, M. (2019) · Archivos de Bronconeumología · doi:10.1016/j.arbr.2019.05.012 · Cited by 10
Martín, M., Millán, A. L., Ferraro, F., Tetzlaff, W., Chiappe, E. L., Botta, E., Castro, M., Boero, L. E., Rey, J., Daruich, J. R., et al. (2020) · Bioscience Reports · doi:10.1042/bsr20201916 · Cited by 8
Telomere length and outcome of treatment for pulmonary tuberculosis in a gold mining community
Katoto, P. D., Kayembe‐Kitenge, T., Pollitt, K. J. G., Martens, D. S., Ghosh, M., Nachega, J. B., Nemery, B., & Nawrot, T. S. (2021) · Scientific Reports · doi:10.1038/s41598-021-83281-2 · Cited by 8
Péntek, S., Várnagy, Á., Farkas, B., Mauchart, P., Gödöny, K., Varjas, T., Kőszegi, T., Kaltenecker, P., Jakabfi-Csepregi, R., Kovács, K. A., et al. (2023) · Antioxidants · doi:10.3390/antiox12020419 · Cited by 10
Polonio, A. M., Medrano, M., Chico-Sordo, L., Córdova-Oriz, I., Cozzolino, M., Montáns, J., Herraiz, S., Seli, E. U., Pellicer, A., García-Velasco, J. A., et al. (2023) · Aging · doi:10.18632/aging.204731 · Cited by 14
Martínez, P., Sánchez-Vazquez, R., Saha, A., Rodríguez-Duque, M. S., Naranjo-Gonzalo, S., Osorio-Chávez, J. S., Villar, A. V., & Blasco, M. A. (2023) · Aging · doi:10.18632/aging.204755 · Cited by 11
Self-citationMathematical model to study the aging of the human follicle according to the telomerase activity
Portillo, A. M., Varela, E., & García-Velasco, J. A. (2018) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2018.11.036 · Cited by 8
Sir4 Deficiency Reverses Cell Senescence by Sub-Telomere Recombination
Liu, J., Hong, X., Wang, L., Liang, C., & Liu, J. (2021) · Cells · doi:10.3390/cells10040778 · Cited by 10
Telomeres in clinical diabetes research – Moving towards precision medicine in diabetes care?
Jenkins, A. J., Syreeni, A., Mutter, S., Januszewski, A. S., & Groop, P. (2022) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2022.110178 · Cited by 7
Evolution of Telomerase Inhibitors: A Review on Key Patents from 2015 to 2023
Dey, R., Vishwakarma, K., Patel, B., Vyas, V. K., & Bhatt, H. (2024) · ChemistrySelect · doi:10.1002/slct.202404444 · Cited by 7
Li, Z., Song, Y., Xu, Y., Shen, Y. L., Zhang, N., Yang, M., & Yu, D. (2020) · Journal of Cancer · doi:10.7150/jca.45165 · Cited by 7
“Multiple studies indicate that telomere length in peripheral blood lymphocytes was significant associated with cancer susceptibility [18-23].”
BackgroundWang, S., Gao, Y., Zhao, L., Hu, R., Yang, X., & Liu, Y. (2021) · Medicine · doi:10.1097/md.0000000000026020 · Cited by 7
“, TTAGGG).([5,6]) These chromosomal caps prevent DNA degradation during replication,([7]) which could otherwise cause deleterious chromosomal fusions.”
BackgroundYin, S., Zhang, F., Song, L., Chen, W., Weng, K., Liu, D., Wang, C., He, Z., Chen, Y., Ma, W., et al. (2022) · Stem Cell Reports · doi:10.1016/j.stemcr.2022.03.005 · Cited by 8
“Pathogenic mutations in telomerase subunits and telomere-binding proteins have been found to disrupt telomeremaintenance and contribute to numerous human diseases, such as dyskeratosis congenita (DC) and cancer (Martinez and Blasco, 2017).”
BackgroundPortillo, A. M., & Peláez-Rodríguez, C. (2021) · Mathematical Medicine and Biology A Journal of the IMA · doi:10.1093/imammb/dqab004 · Cited by 7
M’kacher, R., Breton, L., Colicchio, B., Puget, H., Hempel, W. M., Jawhari, M. A., Jeandidier, É., & Frey, M. (2019) · Cellular and Molecular Biology · doi:10.14715/cmb/2019.65.8.9 · Cited by 7
“Such cells could be the origin of age-related diseases (28) .”
BackgroundExploring the causal relationship between telomere regulation, aging and neurological disorders
Gupta, G., Ali, H., Singh, S. K., Dua, K., & Jha, S. K. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102930 · Cited by 8
Mulet, A., González‐Cabo, P., Pallardó, F. V., & Signes‐Costa, J. (2023) · Archivos de Bronconeumología · doi:10.1016/j.arbres.2023.11.003 · Cited by 6
Feijing, Z., Sun, Z., Cheng, L., & Dong, Y. (2024) · Laboratory Investigation · doi:10.1016/j.labinv.2024.102169 · Cited by 7
Exploring the Mechanisms of Testicular Aging: Advances in Biomarker Research
Chen, W., Zou, H., Xu, H., Cao, R., Zhang, Y., Ma, Y., Wei, L., Zhang, H., & Zhao, J. (2025) · Aging and Disease · doi:10.14336/ad.2025.0070 · Cited by 10
“Telomere shortening accompanies cell division, and critically short or dysfunctional telomeres may trigger a DNA damage response, leading to cellular replicative senescence [55].”
Telomeres, Telomerase and Cancer
Tomita, K., & Collopy, L. C. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.65017-1 · Cited by 7
Wang, D.-X., Zhu, X., Ma, X.-R., Wang, L., Dong, Z.-J., Lin, R., Cao, Y., & Zhao, J. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.726345 · Cited by 6
“…acknowledged that telomere maintenance is an integrative indicator of the overall health and life span, whereas telomere attrition is an interactive contributor to the progress of aging and age-related diseases in organismal individuals (Martinez and Blasco, 2017; Roake and Artandi, 2020).”
BackgroundGhanem, N. Z., Malla, S. R. L., Araki, N., & Lewis, L. K. (2019) · Experimental Cell Research · doi:10.1016/j.yexcr.2019.05.005 · Cited by 7
Molecular insight of dyskeratosis congenita: Defects in telomere length homeostasis
Dorgaleleh, S., Naghipoor, K., Hajimohammadi, Z., Dastaviz, F., & Oladnabi, M. (2022) · Journal of Clinical and Translational Research · doi:10.18053/jctres.08.202201.002 · Cited by 6
“Vertebrate telomeres are a hexanucleotide complex of TTAGGG repeats, with the range between 10 to 15 kb in humans and 25 to 50 kb at the ends of mouse chromosomes [1].”
BackgroundFertility, IVF and reproductive genetics
Varela, E., Sánchez-de-Puerta, I., & García-Velasco, J. A. (2018) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/gco.0000000000000456 · Cited by 6
Proton-Transfer Reactions in One-Electron-Oxidized G-Quadruplexes: A Density Functional Theory Study
Kumar, A., & Sevilla, M. D. (2022) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.1c10529 · Cited by 5
Zhang, R., Wu, M., Ma, M., Liu, B., Zhang, X., Wei, N., Wang, T., Lv, Y., Xu, C., Wang, J., et al. (2023) · European Journal of Clinical Investigation · doi:10.1111/eci.14056 · Cited by 6
“49 Lifestyle modifications, such as physical activity and dietary changes, have been shown to curtail leukocyte telomere attrition, leading to improved health outcomes.”
BackgroundHuang, W., Li, M., Jin, X., Huang, X., Zhao, W., & Tian, X. (2017) · Oncotarget · doi:10.18632/oncotarget.18589 · Cited by 5
“Many studies have shown that telomere shortening or dysfunction is often acquired during the process of tumorigenesis [1].”
BackgroundTelomere regulation: lessons learnt from mice and men, potential opportunities in horses
Denham, J. (2019) · Animal Genetics · doi:10.1111/age.12870 · Cited by 7
Savoy, C. D., Schmidt, L. A., McGowan, P. O., Saigal, S., & Lieshout, R. J. V. (2020) · Journal of Developmental Origins of Health and Disease · doi:10.1017/s2040174420000409 · Cited by 5
Asha, H., Stadlbauer, P., Martínez‐Fernández, L., Banáš, P., Šponer, J., Improta, R., & Esposito, L. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.11.143 · Cited by 5
Targeting shelterin proteins for cancer therapy
Brankiewicz, W., Kallingal, A., Krzemieniecki, R., & Bagiński, M. (2024) · Drug Discovery Today · doi:10.1016/j.drudis.2024.104056 · Cited by 7
Teixeira, M. Z. (2021) · Homeopathy · doi:10.1055/s-0041-1726008 · Cited by 7
The pathophysiological mechanisms of immunosenescence in coronary artery disease
Bie, H., & Tao, Z. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1686947 · Cited by 4
“Fifth (Lanna et al., 2017; Martínez and Blasco, 2017),correcting cellular senescence at its roots through telomere/telomerase-directed strategies—including indirect telomerase upregulation via the sestrin–p38 axis—may mitigate DNA damage and pro-inflammatory phenotypes while restoring proliferative…”
The telomere connection between aging and cancer: The burden of replication stress and dysfunction
Boccardi, V., & Marano, L. (2025) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2025.112026 · Cited by 5
Alt, C., Tsapekos, M., Perez, D., Klode, J., & Stoffels, I. (2022) · Cosmetics · doi:10.3390/cosmetics9050095 · Cited by 4
“Counteracting telomere attrition and its consequences has been a primary target of research over the past decade [17,18].”
BackgroundTelomere length as a biomarker of aging and diseases
Guzonjić, A., Sopić, M., Ostanek, B., & Kotur‐Stevuljević, J. (2022) · Arhiv za farmaciju · doi:10.5937/arhfarm72-36376 · Cited by 5
Telomere Dysfunction in Renal Tubular Epithelial Cells Leads to Kidney Fibrosis
Saraswati, S., Martínez, P., Serrano, R., Megías, D., Graña‐Castro, O., Álvarez, R., Flores, J. M., & Blasco, M. A. (2025) · Journal of the American Society of Nephrology · doi:10.1681/asn.0000000771 · Cited by 4
“51,52 To the best of our knowledge, this is the fi rst study showing that telomere dysfunction speci fi cally in renal tubular epithelial cells increases the susceptibility to develop kidney fi brosis by reducing the kidney ’ s ability to repair itself after injury.”
Self-citationFranzoni, L. T., Garcia, E. L., da Motta, S. B., Ahner, M. M., Bertoletti, O. A., Saffi, M. A. L., da Silveira, A. D., Pereira, A. A., Pereira, A. H., Danzmann, L. C., et al. (2022) · Trials · doi:10.1186/s13063-022-06257-1 · Cited by 3
“Discussion Telomere and its length have been studied as a biological marker of aging and are considered a therapeutic target, not only in patients, but also in healthy individuals [51, 52].”
BackgroundKlinaki, E., & Ogrodnik, M. B. (2024) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2024.111929 · Cited by 3
Telomerase activation and human health-span: an open issue
Boccardi, V., & Mecocci, P. (2017) · Aging Clinical and Experimental Research · doi:10.1007/s40520-017-0766-z · Cited by 3
Muthanandam, S., Kanipakam, Y., Rajaram, S., Vezhavendhan, N., Maddileti, B., Arumugam, S. D., Santhanam, V., & Chinnadurai, R. K. (2021) · World Journal of Dentistry · doi:10.5005/jp-journals-10015-1854 · Cited by 3
The role of telomere dysfunction in genomic instability and age-related diseases
Xu, L., Zhang, K., & Cong, Y. (2021) · Genome Instability & Disease · doi:10.1007/s42764-021-00052-z · Cited by 3
ShRNA-mediated silencing of hTERT promote apoptosis and senescence in human ovarian cancer cells
Chen, S., Luo, Y., Yang, Y., & Yi, Y. (2019) · Translational Cancer Research · doi:10.21037/tcr.2019.03.17 · Cited by 3
“com with carcinogenesis, telomere abnormalities also play a key role in cancer progression (10).”
BackgroundKüçüksolak, M., Coban, H. B., & Bedіr, E. (2024) · Microbial Cell Factories · doi:10.1186/s12934-024-02468-0 · Cited by 3
“Congenital dyskeratosis, aplastic anemia, and pulmonary fibrosis are among the diseases that can also be caused by telomere dysfunction [3, 4].”
BackgroundPortillo, A. M., García-Velasco, J. A., & Varela, E. (2024) · Mathematical Biosciences · doi:10.1016/j.mbs.2024.109305 · Cited by 4
Andreikos, D., Spandidos, D. A., & Georgakopoulou, V. (2025) · International Journal of Oncology · doi:10.3892/ijo.2025.5729 · Cited by 5
“2) (79).”
Applications of CRISPR-Cas in Ageing Research
Haston, S., Pozzi, S., & González-Meljem, J. M. (2020) · Springer eBooks · doi:10.1007/978-3-030-40955-5_11 · Cited by 5
Maternal testosterone affects offspring telomerase activity in a long‐lived seabird
Noguera, J. C., & Velando, A. (2022) · Ecology and Evolution · doi:10.1002/ece3.9281 · Cited by 2
TLPath predicts telomere length in human tissues from histopathology imagesPreprint
Yadav, A., Alvarez, K., Adeleye, A., Wang, Y. X., & Sinha, S. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.03.04.641489 · Cited by 3
“Overall, telomere dysfunction has emerged as a key driver of multiple age-related pathologies, with blood-based telomere length shown to be a predictor of disease progression and mortality in conditions ranging from idiopathic pulmonary fibrosis to cardiovascular diseases (2, 4).”
Buczyńska, A., Sidorkiewicz, I., Kosinski, P. D., Kretowski, A. J., & Zbucka-Krętowska, M. (2025) · Cells · doi:10.3390/cells14141059 · Cited by 2
“These strategies aim to assess their potential for enhancing health, extending lifespan, and treating short telomere syndromes [51,52].”
Expanding the Morphologic and Molecular Spectrum of Spindle Cell Tumors Associated With TERT Fusions
Hue, S. S., Saoud, C., Bahceci, D. H., Villafania, L. B., Benhamida, J. K., & Antonescu, C. R. (2025) · Genes Chromosomes and Cancer · doi:10.1002/gcc.70097 · Cited by 2
Network-level control of G protein-coupled receptors: a panacea for chronic diseases?
Boeringer, T., Pardo, M., Craig, C. J., Pozo, A. D., Ladds, G., Hébert, T. E., Dodel, S., Prentice, H., Bejanyan, R., & Maudsley, S. (2026) · Frontiers in Science · doi:10.3389/fsci.2026.1891819 · Cited by 2
“Progressive telomere shortening induces senescence and tissue dysfunction, promoting endothelial dysfunction, atherosclerosis, heart failure, fi broblast activation, and organ fi brosis (e.g., idiopathic pulmonary fi brosis and chronic kidney disease) (127, 128).”
Lawrence, T., & Murphy, T. M. (2018) · OBM Genetics · doi:10.21926/obm.genet.1804055 · Cited by 2
Exercise to combat cancer: focusing on the ends
Denham, J., Bliss, E., Bryan, T. M., O’Brien, B. J., & Mills, D. E. (2024) · Physiological Genomics · doi:10.1152/physiolgenomics.00075.2024 · Cited by 3
Metadata
- Authors
- Martínez, P., & Blasco, M. A.
- Affiliations
- Spanish National Cancer Research Centre (ES)
- Telomeres and Telomerase Group, Molecular Oncology Program, Spanish National Cancer Centre, Madrid E-28029, Spain
- Venue
- Journal of Cell Biology
- Publisher
- Rockefeller University Press
- Published
- 2017-03-02
- Volume
- 216
- Issue
- 4
- Pages
- 875-887
- ISSN
- 0021-9525 (ISSN-L)
- 1540-8140
- PMC
- PMC5379954
- OpenAlex
- W2592919828
- Cited by
- 257
- References
- 148
- Citations by year
- 2026: 13 · 2025: 20 · 2024: 22 · 2023: 21 · 2022: 33 · 2021: 43 · 2020: 38 · 2019: 21 · 2018: 33 · 2017: 13
- FWCI
- 3.52
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- The Journal of Cell Biology (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, other-oa)
- Funders
- Spanish Ministry of Economy and Competitiveness
- Fondo Europeo de Desarrollo Regional (SAF2013-45111-R)
- European Research Council (ERC-2008-AdG/232854)
- Fundación Botín
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Structure and Function
- Keywords
- telomeres, telomere shortening, aging, Hoyeraal-Hreidarsson syndrome, dyskeratosis congenita, pulmonary fibrosis, aplastic anemia, liver fibrosis, chromosomal instability, carcinogenesis, shelterin, telomere maintenance genes, cancer, stem cell proliferation, mouse model
- MeSH terms
- Aging, Animals, Cell Transformation, Neoplastic, Fetal Growth Retardation, Humans, Intellectual Disability, Microcephaly, Mutation, Neoplasms, Telomere, Telomerase, Dyskeratosis Congenita, Chromosomal Instability, Molecular Targeted Therapy, Telomere Homeostasis, Telomere Shortening
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.